PON1 and Alzheimer disease: Three main biomarkers, Paraoxonase-1 (PON-1) in CVD, Matrix Metalloproteases (MMPs) in both CVD and neurological diseases, and Beta-Secretase-1 (BACE-1) in AD have been proposed as indicator of sex-specific disease phenotypes [25–27].